LB54640
A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic Obesity
Rhythm · Phase 2 · Status n/r · Enrollment 4
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| POMC/PCSK1/LEPR cohort | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.